Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice

Naomi Jessurun; Eugène P. van Puijenbroek; Leila S. Otten; Oenone Mikes; Annemieke Vermeulen Windsant; Rob J. van Marum; Koen Grootens; Hieronymus J. Derijks

doi:10.1111/bcp.13201

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice

Naomi Jessurun^*, Eugène P. van Puijenbroek, Leila S. Otten, Oenone Mikes, Annemieke Vermeulen Windsant, Rob J. van Marum, Koen Grootens, Hieronymus J. Derijks

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1149-1151
Number of pages	3
Journal	British Journal of Clinical Pharmacology
Volume	83
Issue number	5
DOIs	https://doi.org/10.1111/bcp.13201
Publication status	Published - 2017

Access to Document

10.1111/bcp.13201

Cite this

Jessurun, N., van Puijenbroek, E. P., Otten, L. S., Mikes, O., Vermeulen Windsant, A., van Marum, R. J., Grootens, K., & Derijks, H. J. (2017). Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice. British Journal of Clinical Pharmacology, 83(5), 1149-1151. https://doi.org/10.1111/bcp.13201

@article{8c9435e1a1b743a2bd8a4acb09d92fe5,

title = "Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice",

author = "Naomi Jessurun and {van Puijenbroek}, {Eug{\`e}ne P.} and Otten, {Leila S.} and Oenone Mikes and {Vermeulen Windsant}, Annemieke and {van Marum}, {Rob J.} and Koen Grootens and Derijks, {Hieronymus J.}",

year = "2017",

doi = "10.1111/bcp.13201",

language = "English",

volume = "83",

pages = "1149--1151",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell",

number = "5",

}

Jessurun, N, van Puijenbroek, EP, Otten, LS, Mikes, O, Vermeulen Windsant, A, van Marum, RJ, Grootens, K & Derijks, HJ 2017, 'Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice', British Journal of Clinical Pharmacology, vol. 83, no. 5, pp. 1149-1151. https://doi.org/10.1111/bcp.13201

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice. / Jessurun, Naomi; van Puijenbroek, Eugène P.; Otten, Leila S. et al.

In: British Journal of Clinical Pharmacology, Vol. 83, No. 5, 2017, p. 1149-1151.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice

AU - Jessurun, Naomi

AU - van Puijenbroek, Eugène P.

AU - Otten, Leila S.

AU - Mikes, Oenone

AU - Vermeulen Windsant, Annemieke

AU - van Marum, Rob J.

AU - Grootens, Koen

AU - Derijks, Hieronymus J.

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85011088282&partnerID=8YFLogxK

U2 - 10.1111/bcp.13201

DO - 10.1111/bcp.13201

M3 - Article

C2 - 28133768

AN - SCOPUS:85011088282

SN - 0306-5251

VL - 83

SP - 1149

EP - 1151

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 5

ER -

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice

Access to Document

Other files and links

Cite this